Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control
RBR Muijsers, AJ Wagstaff - Drugs, 2001 - Springer
Fentanyl is a synthetic opioid agonist which interacts primarily with the μ-opioid receptor.
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
RB Muijsers, AJ Wagstaff - Drugs, 2001 - europepmc.org
Conclusion Transdermal fentanyl is a useful opioid-agonist for the treatment of moderate to
severe chronic cancer pain. The advantages of transdermal fentanyl include ease of …
severe chronic cancer pain. The advantages of transdermal fentanyl include ease of …
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control
RB Muijsers, AJ Wagstaff - Drugs, 2001 - pubmed.ncbi.nlm.nih.gov
Fentanyl is a synthetic opioid agonist which interacts primarily with the mu-opioid receptor.
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
Transdermal Fentanyl: An Updated Review of its Pharmacological Properties and Therapeutic Efficacy in Chronic Cancer Pain Control.
RBR Muijsers, AJ Wagstaff - Drugs, 2001 - search.ebscohost.com
Fentanyl is a synthetic opioid agonist which interacts primarily with the µ-opioid receptor.
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
[引用][C] Transdermal fentanyl: An updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control
RBR MUIJSERS, AJ WAGSTAFF - Drugs (Basel), 2001 - pascal-francis.inist.fr
Transdermal fentanyl: An updated review of its pharmacological properties and therapeutic
efficacy in chronic cancer pain control CNRS Inist Pascal-Francis CNRS Pascal and Francis …
efficacy in chronic cancer pain control CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[引用][C] Transdermal Fentanyl
RBR Muijsers, AJ Wagstaff - Drugs, 2001 - cir.nii.ac.jp
Transdermal Fentanyl | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細
へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …
へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …
Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
RB Muijsers, AJ Wagstaff - Drugs, 2001 - search.ebscohost.com
Fentanyl is a synthetic opioid agonist which interacts primarily with the mu-opioid receptor.
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …
[引用][C] Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control
BR RICHARD - Drugs, 2001 - cir.nii.ac.jp
Transdermal fentanyl : an updated review of its pharmacological properties and therapeutic
efficacy in chronic cancer pain control | CiNii Research CiNii 国立情報学研究所 学術情報 …
efficacy in chronic cancer pain control | CiNii Research CiNii 国立情報学研究所 学術情報 …